313257-47-5

Basic information

• Product Name: N-[(1-methylpiperidin-2-yl)methyl]-N-phenylindan-2-yl-amine
• Synonyms: N-[(1-methylpiperidin-2-yl)methyl]-N-phenylindan-2-yl-amine
• CAS NO: 313257-47-5
• Molecular Weight: 320.478
• Mol File: 313257-47-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: N-[(1-methylpiperidin-2-yl)methyl]-N-phenylindan-2-yl-amine(CAS DataBase Reference)
• NIST Chemistry Reference: N-[(1-methylpiperidin-2-yl)methyl]-N-phenylindan-2-yl-amine(313257-47-5)
• EPA Substance Registry System: N-[(1-methylpiperidin-2-yl)methyl]-N-phenylindan-2-yl-amine(313257-47-5)

Safety Data

• Hazardous Substances Data: 313257-47-5(Hazardous Substances Data)

Upstream product

• 313257-54-4 N-[(1-benzylpiperidin-2-yl)methyl]-N-phenylindan-2-yl-amine 
• 33237-72-8 indan-2-yl anilide 
• 137650-02-3 (1-benzylpiperidin-2-yl)methanol 
• 129437-88-3 1-benzyl-2-(chloromethyl)piperidine 
• 3433-37-2 piperidin-2-ylmethanol 
• 62-53-3 aniline 
• 615-13-4 2-indanone 

Downstream Products

• 1393836-33-3 1,1-dimethyl-2-[((indan-2-yl)(phenyl)amino)methyl]piperidinium iodide 

Relevant articles and documents

USE OF AMINOINDANE COMPOUNDS IN TREATING OVERACTIVE BLADDER AND INTERSTITIAL CYSTITIS

The present application provides methods of using the aminoindane compounds of formula (I) or (II) in treating an overactive bladder or interstitial cystitis by administering one or more of the compounds to a patient.

Dermal anesthetic agents

The present invention relates to new aminoindane piperidine compounds, the method of using aminoindane compounds as local anesthetics, said compounds having particularly valuable properties as dermal and topical anesthetics in mammals, including man, as well as compositions containing said compounds.